<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>건강과 대안 &#187; 신종플루 사망자 225명</title>
	<atom:link href="http://www.chsc.or.kr/tag/%EC%8B%A0%EC%A2%85%ED%94%8C%EB%A3%A8%20%EC%82%AC%EB%A7%9D%EC%9E%90%20225%EB%AA%85/feed" rel="self" type="application/rss+xml" />
	<link>http://www.chsc.or.kr</link>
	<description>연구공동체</description>
	<lastBuildDate>Mon, 13 Apr 2026 01:34:28 +0000</lastBuildDate>
	<language>ko-KR</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.2</generator>
		<item>
		<title>[돼지독감] 신종플루 사망자 225명(1.30 기준)</title>
		<link>http://www.chsc.or.kr/?post_type=reference&#038;p=1782</link>
		<comments>http://www.chsc.or.kr/?post_type=reference&#038;p=1782#comments</comments>
		<pubDate>Thu, 04 Feb 2010 17:14:31 +0000</pubDate>
		<dc:creator>건강과대안</dc:creator>
				<category><![CDATA[식품 · 의약품]]></category>
		<category><![CDATA[가짜 대유행 논란]]></category>
		<category><![CDATA[돼지독감]]></category>
		<category><![CDATA[보건복지가족부]]></category>
		<category><![CDATA[신종플루]]></category>
		<category><![CDATA[신종플루 사망자 225명]]></category>

		<guid isPermaLink="false">http://www.chsc.or.kr/?post_type=reference&#038;p=1782</guid>
		<description><![CDATA[주간(1.10~1.16) 발생 현황□ 신종플루 환자 중 합병증 입원 사례 현황(1.30 기준)&#160;○ 총 20명이 중증 합병증으로 중환자실 입원 중&#160;○ 신종플루 관련 사망사례 7건 추가 : 총 225건&#160; 총 사망자 [...]]]></description>
				<content:encoded><![CDATA[<p><P><BR>주간(1.10~1.16) 발생 현황<BR><BR>□ 신종플루 환자 중 합병증 입원 사례 현황(1.30 기준)<BR><BR>&nbsp;○ 총 20명이 중증 합병증으로 중환자실 입원 중<BR>&nbsp;○ 신종플루 관련 사망사례 7건 추가 : 총 225건<BR><BR>&nbsp;<A name="[문서의 처음]"></A></P><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '한컴바탕'; TEXT-ALIGN: justify"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '한컴바탕'; LETTER-SPACING: 0px; TEXT-ALIGN: justify"><A name=#4eceb5ab></A></SPAN><br />
<TABLE style="BORDER-RIGHT: medium none; BORDER-TOP: medium none; BORDER-LEFT: medium none; BORDER-BOTTOM: medium none; BORDER-COLLAPSE: collapse" height=93 cellSpacing=0 cellPadding=6 width=545 border=1><br />
<TBODY><br />
<TR><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=63 bgColor=#ffffff height=65 rowSpan=2><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">총 사망자</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=85 bgColor=#ffffff colSpan=2 height=27><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">성 별</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=395 bgColor=#ffffff colSpan=7 height=27><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">연 령 별</SPAN></P></TD></TR><br />
<TR><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=42 bgColor=#ffffff height=38><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; LETTER-SPACING: -3px; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: -3px; TEXT-ALIGN: center">남</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=42 bgColor=#ffffff height=38><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; LETTER-SPACING: -3px; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: -3px; TEXT-ALIGN: center">여</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=50 bgColor=#ffffff height=38><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">0-9</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=52 bgColor=#ffffff height=38><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">10-19</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=57 bgColor=#ffffff height=38><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">20-29</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=53 bgColor=#ffffff height=38><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">30-39</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=53 bgColor=#ffffff height=38><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">40-49</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=65 bgColor=#ffffff height=38><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">50-59</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=62 bgColor=#ffffff height=38><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">60 이상</SPAN></P></TD></TR><br />
<TR><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=63 bgColor=#ffffff height=27><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">225</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=42 bgColor=#ffffff height=27><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">121</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=42 bgColor=#ffffff height=27><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">104</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=50 bgColor=#ffffff height=27><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">16</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=52 bgColor=#ffffff height=27><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">6</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=57 bgColor=#ffffff height=27><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">8</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=53 bgColor=#ffffff height=27><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">15</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=53 bgColor=#ffffff height=27><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">19</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=65 bgColor=#ffffff height=27><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">36</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=62 bgColor=#ffffff height=27><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">125</SPAN></P></TD></TR></TBODY></TABLE><SPAN></SPAN></P><br />
<P><BR><BR>========================<BR><BR><STRONG><FONT size=3>신종인플루엔자 감소세 유지, 그러나 ILI는 소폭 증가<BR></FONT></STRONG><BR>출처 : 보건복지가족부 보도자료 2010-02-04<BR><A href="http://www.mw.go.kr/front/al/sal0301vw.jsp?PAR_MENU_ID=04&#038;MENU_ID=0403&#038;page=1&#038;BOARD_ID=140&#038;BOARD_FLAG=&#038;CONT_SEQ=226857&#038;SEARCHKEY=&#038;SEARCHVALUE=&#038;CREATE_DATE1=&#038;CREATE_DATE2">http://www.mw.go.kr/front/al/sal0301vw.jsp?PAR_MENU_ID=04&#038;MENU_ID=0403&#038;page=1&#038;BOARD_ID=140&#038;BOARD_FLAG=&#038;CONT_SEQ=226857&#038;SEARCHKEY=&#038;SEARCHVALUE=&#038;CREATE_DATE1=&#038;CREATE_DATE2</A>=<BR><BR>중앙인플루엔자 대책본부(본부장 : 전재희 보건복지가족부 장관)는, 5주차(1.24~1.30) ILI가 5.39로, 아직도 유행기준(2.6)을 초과하고 있고, 개학과 설 명절을 계기로 면역이 형성되지 않은 집단에서 소규모 유행 가능성을 배제할 수 없다고 하면서 현재까지 신종플루 우선 접종대상자 중 약 1,200만명이 접종(사전예약대비 84%)을 받았으며, 만성질환자와 65세 이상 노인 등 고위험군의 경우, 3월초까지 접종을 완료토록 할 것이라고 함</P><br />
<P>&nbsp;</P><br />
<P>&nbsp;예방접종을 받지 않는 만성질환자, 고령자 등 감염으로 인한 합병증 발생 위험이 높은 고위험군은 조속한 시일 안에 예방접종 받을 것을 당부함</P><br />
<P><BR>&nbsp;대책본부는 2010년 5주차(1.24~1.30) 인플루엔자 유사환자 분율(ILI)이 5.39로, 지난주(4주차 : 5.12) 대비 5.3% 증가 하였으나, 항바이러스제 일일 처방건수는 3,989건(7.7%↓)으로 계속 감소하고 있다고 하면서 세계보건기구(WHO)의 발표에 따르면 2010.1.29일 현재 대부분의 북반구지역 국가에서는 유행 정점을 지났으나, 일부 북아프리카, 동유럽, 동남아시아 일부에서는 아직도 전파가 활발한 상황이라고 함<BR></P></p>
]]></content:encoded>
			<wfw:commentRss>http://www.chsc.or.kr/?post_type=reference&#038;p=1782/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
